In a large prospective study, a low MIP-1α concentration has been associated with an increased risk for CRC [65]; in another one, increased serum concentrations of MIP-1β were found to predict improved disease-free survival [78]. This evidence concerns the gene CCL3 and colorectal carcinoma.